Newsmaker | 'Upgrade Quality or Risk Shutdowns': How India's New DCGI is Rebuilding 'Pharmacy of the World'

In February, India appointed Raghuvanshi, the first DCGI from the corporate world who boasted of stints at Ranbaxy and Dr. Reddy’s among others

Related Keywords

United States ,Uzbekistan ,Marshall Islands ,Gambia ,Matai ,India General ,India ,Sri Lanka ,Micronesia ,Rajeev Singh Raghuvanshi ,Viranchi Shah ,Indian Pharma ,Indian Drug Manufacturer Association ,Medium Small Pharma Companies ,Novartis ,World Health Organization ,Central Drugs Standard Control Organization ,Organisation Of Pharmaceutical Producers India ,Ministry Of Commerce ,Union Territories ,Ministry Of Health ,Drug Controller General ,Singh Raghuvanshi ,Anil Matai ,Pharmaceutical Producers ,Medical Devices ,Cosmetics Bill ,Drugs Bill ,Indian Pharmaceutical Alliances ,Not Standard Quality ,Good Manufacturing Practices ,Meftal Spas ,Directorate General ,Foreign Trade ,Foreign Trade Policy ,Propylene Glycol ,Codeine Based Cough ,Small Pharma ,Family Welfare ,Drug Controller General Of India ,The Gambia ,